Robert Berman, Special Projects & Med Ovrsght at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 249,700 shares at $52.95 ($13.3M) on 2019-12-30, disclosed to the SEC on 2019-12-31.
Open-market sale of $13.3M BHVN by Special Projects & Med Ovrsght. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.95 | 67,450 | $3.6M | 26.9% |
| 2 | $52.95 | 67,450 | $3.6M | 26.9% |
| 3 | $53.43 | 53,762 | $2.9M | 21.6% |
| 4 | $53.43 | 53,762 | $2.9M | 21.6% |
| 5 | $54.89 | 3,488 | $191K | 1.4% |
| 6 | $54.89 | 3,488 |
| $191K |
| 1.4% |
| 7 | $55.97 | 300 | $17K | 0.1% |
| Total | $53.21 avg | 249,700 | $13.3M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |
| BHVN | SELL | 2018-06-20 | $2.6M | — | Filing → |